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Abstract

Objective To determine women's preferences for and reported experience with medical test decision-making.
Design Computer-assisted telephone survey. Setting and participants Six hundred and fifty-two women
resident in households randomly selected from the New South Wales electronic white pages. Main outcome
measures Reported and preferred test and treatment (for comparison) decision-making, satisfaction with and
anxiety about information on false results and side-effects; and effect of anxiety on desire for such
information. Results Overall most women preferred to share test (94.6%) and treatment (91.2%) decisionmaking equally with their doctor, or to take a more active role, with only 5.4-8.9% reporting they wanted the
doctor to make these decisions on their behalf. This pattern was consistent across all age groups. In general,
women reported experiencing a decision-making role that was consistent with their preference. Women who
had a usual doctor were more likely to report experiencing an active role in decision-making. More women
reported receiving as much information as they wanted about the benefits of tests and treatment than about
the side-effects of tests and treatment. Most women wanted information about the possibility of false test
results (91.5%) and test side-effects (95.6%), but many reported the doctor never provided this information
(false results = 40.0% and side-effects = 31.3%). A substantial proportion said this information would make
them anxious (false results = 56.6% and side-effects = 43.1%), but reported they wanted the information
anyway (false results = 77.6% and side-effects = 88.1%). Conclusions Women prefer an active role in test and
treatment decision-making. Many women reported receiving inadequate information. If so, this may
jeopardize informed decision-making.
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Objective To determine women’s preferences for and reported
experience with medical test decision-making.
Design Computer-assisted telephone survey.
Setting and participants Six hundred and ﬁfty-two women resident
in households randomly selected from the New South Wales
electronic white pages.
Main outcome measures Reported and preferred test and treatment
(for comparison) decision-making, satisfaction with and anxiety
about information on false results and side-eﬀects; and eﬀect of
anxiety on desire for such information.
Results Overall most women preferred to share test (94.6%) and
treatment (91.2%) decision-making equally with their doctor, or to
take a more active role, with only 5.4–8.9% reporting they wanted the
doctor to make these decisions on their behalf. This pattern was
consistent across all age groups. In general, women reported
experiencing a decision-making role that was consistent with their
preference. Women who had a usual doctor were more likely to report
experiencing an active role in decision-making. More women reported
receiving as much information as they wanted about the beneﬁts of
tests and treatment than about the side-eﬀects of tests and treatment.
Most women wanted information about the possibility of false test
results (91.5%) and test side-eﬀects (95.6%), but many reported the
doctor never provided this information (false results ¼ 40.0% and
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side-eﬀects ¼ 31.3%). A substantial proportion said this information
would make them anxious (false results ¼ 56.6% and sideeﬀects ¼ 43.1%), but reported they wanted the information anyway
(false results ¼ 77.6% and side-eﬀects ¼ 88.1%).
Conclusions Women prefer an active role in test and treatment
decision-making. Many women reported receiving inadequate
information. If so, this may jeopardize informed decision-making.

Introduction
Decision-making shared by patients and doctors
is advocated to involve patients in decisions
about their care.1–6 However, advocating such a
role for patients ignores variation in patientsÕ
preferences for involvement in decision-making.
While some patients want to make decisions
themselves, others prefer to delegate decisionmaking to their doctor or share decision-making
with their doctor. Previous studies have reported
wide variation in preferences for involvement in
decision-making about treatment.7–15 Many of
the studies looking at treatment decision-making
have been conducted with patients already in the
health-care system7–15 who are more likely to
select a passive decision-making role than
healthy people.11 The few studies that have used
a community-based sample16 or included nonpatient samples for comparison,11,14,15 have focused on decision-making preferences regarding
treatment, to the exclusion of preferences for test
decision-making. There are no data about preferences in relation to test decision-making and the
extent to which these preferences would mirror
results for treatment is unclear. Community
sampling is necessary for eliciting information
about test decision-making, as decisions about
whether to undergo a screening and/or diagnostic
test are usually the entry point to the health system made by people living in the community. The
General Medical Council in the United Kingdom17 recently provided guidance to health care
providers about information that should be given
to people considering screening tests. To our
knowledge, no similar guidance is available about
information that should be given to people
undergoing diagnostic tests.

It is currently unknown whether people want
to participate in decisions about whether to
undergo screening and diagnostic tests, whether
they feel they are currently participating in these
decisions, what information they are currently
receiving and what information they would like
to receive. Therefore, the aims of this study were
to: (1) elicit women’s preferences for test and
treatment (for comparison) decision-making;
(2) compare these to their reported experiences
of medical test, breast test and treatment decision-making; and (3) assess women’s preferences
for information concerning false test results and
test side-eﬀects and their predicted anxiety about
such information.

Methods
Participants
The sample consisted of women aged
30–69 years inclusive, who were resident in New
South Wales (NSW) at the time the study was
conducted, had access to a telephone listed in the
electronic white pages and spoke English well
enough to participate in a telephone interview.
This age group is consistent with a previous
survey on breast health18–20 and includes both
the age range with high rates of breast symptoms
and breast tests21 and the age range targeted by
the national mammographic screening programme.22 Although this programme is specifically aimed at women aged 50–69 years, it oﬀers
free mammograms to all women aged 40 years
and over who have no symptoms of breast
cancer. Therefore, the sample is likely to include
many women who have had personal experience
with breast tests.
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Procedure
The Hunter Valley Research Foundation
administered the survey using a ComputerAssisted Telephone Interviewing (CATI) system.
Households randomly selected from the NSW
electronic white pages were sent a letter introducing the study 1 week before the ﬁrst telephone contact. Up to 10 attempts were made to
contact the household. Once a household was
contacted, the interviewer asked if a person ﬁtting the eligibility criteria (an English-speaking
woman aged 30–69 years inclusive) lived in the
house. Where more than one person ﬁtted the
criteria, the number of people ﬁtting the criteria
was obtained and the CATI program selected
one person at random (e.g. oldest, third oldest).
Once a person was selected, no substitution was
permitted. If she was unavailable, up to ﬁve
further call attempts were made. The survey
took approximately 20 min. Quotas were used
to ensure at least 150 women were interviewed
within each decade of age (30–39, 40–49, 50–59,
60–69) as responses from women from all age
categories were of equal interest and we wanted
good precision (95% conﬁdence intervals of
±8%) for estimates in the older age groups.
The Human Ethics Committee of The University of Sydney approved the study.
Survey development
The survey consisted of six sections designed to
elicit information on women’s sociodemographic details, preferences for test and treatment decision-making, reported test, breast test
and treatment decision-making, and information needs related to medical tests. The majority
of the survey consisted of questions developed
by the researchers. Published questions were
available for the sections on preferred decisionmaking role. Questions in this section of the
survey were adapted from The Control Preferences Scale,23 which uses ﬁve cards in a series of
two-card comparisons to elicit information on
respondentsÕ desired role in decision-making.
Initially developed using analysis of the way
treatment decisions are made by patients, it has

been used to measure preferences in patient and
non-patient populations.23 A ﬁnal draft of the
survey was pilot tested to establish reliability
and facilitate the revision of problematic questions. To establish test–retest reliability, 106
women completed the survey once and then
again 1 week later. Questions and response
options were presented in the same order for
both administrations.
Reliability was assessed by the percentage of
responses with exact agreement on both occasions and using j (for categorical variables) and
weighted j (for ordinal variables) statistics.
Comparison of answers given on both occasions
showed agreement of 80% or higher for 44% of
the questions, 60–79% for 41% of the questions
and 50–59% for the remaining 15% of questions. Using Landis and Koch’s classiﬁcation,24
15% of questions had j or weighted j in the
Ôalmost perfectÕ range (0.81–1.00), 18% of questions were in the ÔsubstantialÕ range (0.61–0.80),
41% were in the ÔmoderateÕ range (0.41–0.60),
21% the ÔfairÕ range (0.21–0.40) and 6% had j
below 0.20. A review of the questions showed
that j and weighted j were high on questions
that would be expected to stay the same, such as
demographic items and items asking about previous tests (for example, Have you ever had a
mammogram?, j ¼ 0.981). Reliability for these
items was comparable with a previous Australian survey of women in the same age range.20
Items with lower j were judgment or preference
questions (such as were you given enough information about the potential beneﬁts of the test?),
which previous research shows change over
time.25 Minor changes were made to the wording
of some questions to facilitate respondent
understanding. The survey was then pilot tested
with a further sample of 30 women to assess the
acceptability of the changes. The ﬁnal version of
the survey consisted of six sections. A copy of the
survey is available on request.
Sociodemographic details
Information was obtained on participantsÕ age,
suburb or town of residence, postcode, country
of birth, highest level of education completed
and employment status.
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Preferred test and treatment decision-making
This section was designed to elicit decisionmaking role preferences. Participants were asked
to imagine a hypothetical situation in which they
were considering whether or not to undergo a
cholesterol test. To elicit a test decision-making
preference from among the ﬁve options, each
participant was taken through a series of questions comparing two options at a time, using the
same approach as the card sort method developed by Degner and colleagues.23 In summary,
the options provided were: (a) she makes decisions alone; (b) she makes decisions after seriously considering the doctor’s opinion; (c) she
shares decision-making equally with the doctor;
(d) the doctor makes decisions after seriously
considering her opinion; and (e) the doctor
makes decisions alone. The full wording of each
option is available in the questionnaire. The
same method was used to elicit the participant’s
preferred treatment decision-making role. Participants were asked to imagine they were
making a decision such as whether to take the
oral contraceptive pill or hormone replacement
therapy.
Reported test and treatment decision-making
Participants were asked a series of questions
about communication and decision-making with
their current or last doctor. Questions elicited
information on: whether women had a usual
doctor and if so, what type of doctor this was;
what role women played in making test
decisions; and if they received enough information about test beneﬁts and side-eﬀects. In
regards to reported test decision-making,
participants were given two examples of a test
(blood test for cholesterol and X-rays for suspected broken bones), asked to name a test they
had undergone (screening or diagnostic) and to
choose their decision-making role for that test
from one of three options, which were: (a) she
made the decision alone; (b) she shared decisionmaking equally with the doctor; and (c) the
doctor made the decision alone. Analogous
questions were used to elicit information on
the participant’s reported treatment decisionmaking role.

Reported decision-making role for breast tests
Participants were informed that tests for breast
disease included mammography and breast
biopsy. For mammograms, speciﬁc questions
pertained to: whether women had ever had a
mammogram; purpose of the mammogram
(screening or diagnostic); time since last
mammogram; information about potential
beneﬁts and side-eﬀects; and decision-making
involvement. For biopsy, questions elicited
information on: whether women had ever
undergone a breast biopsy; time since last
biopsy; and information received about beneﬁts
and side-eﬀects.
Information on test accuracy
Participants were informed that few tests are
100% accurate and that sometimes tests are
normal in people who really have a disease and
abnormal in healthy people. Participants were
also informed that tests can have side-eﬀects and
were given the example of breast biopsy, which
can have side eﬀects of pain, bleeding and/or
infection. This was followed by questions eliciting information on: (a) the perceived frequency
of receiving information about false results and
side-eﬀects; (b) desire for this information; (c)
perceived anxiety that this information might
create; and (d) views on whether this anxiety
would deter them from wanting the information.
Statistical analysis
Analyses were performed using SPSS v. 10.0 for
Windows.26 Signiﬁcance testing was done using
v2 tests for nominal variables and v2 tests for
trend for ordinal variables, with P values of less
than 0.05 considered statistically signiﬁcant. All
analyses were done separately for women who
reported a usual doctor and those who did not.
Results are reported for women with a usual
doctor only, unless there was a signiﬁcant difference between women with a usual doctor and
women without one. In these instances, results
for women without a usual doctor are reported
separately in the text. Demographic characteristics were examined from the Australian Bureau
of Statistics (ABS) census data27 and data on age
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breakdown, area of residence, education, occupation and country of birth (Australia vs. overseas) were tabulated according to ABS
categories. As we deliberately over sampled
older women, all results are presented as agespeciﬁc rates, or weighted for age where the
weights were derived from the age distribution
of NSW women in the census data.

signiﬁcant diﬀerences between the age-adjusted
survey population and the general population of
women in NSW as derived from Australian
Census data27 for region, education, occupation
and country of birth. Of the women surveyed,
91.1% reported having a usual doctor, 98.9% of
these being a family doctor.
Preferred test and treatment decision-making

Results
Characteristics of the sample population
Of the 743 eligible women contacted, 652 completed the survey, representing an unadjusted
response rate of 87.8%. When adjusted for the
estimated number of eligible women (based on
census data) among the households that could
not be contacted (n ¼ 228) the response rate was
74.1%. Women aged 30–39 years were underrepresented and those aged 60–69 years were
over-represented compared to the population of
women in NSW (see Table 1). There were no
Age-adjusted
study
population (%)

Table 2 shows women’s decision-making preferences for tests and treatment. Most women
preferred to share decision-making with
their doctor. For tests and treatment, women
younger than 60 (v2 ¼ 18.009, 1 df, P < 0.001;
v2 ¼ 9.984, 1 df, P ¼ 0.002, respectively), those
with more education (v2 ¼ 4.532, 1 df, P ¼ 0.033;
v2 ¼ 22.108, 1 df, P < 0.001, respectively) and
women who reported they currently share
decision-making with their doctor (v2 ¼ 29.003,
8 df, P < 0.001; v2 ¼ 64.861, 8df, P < 0.001,
respectively) preferred to make the decision
themselves, either alone or after considering the
General population
women aged
30–69 years* (%)

Characteristic

Study
population (%)

Age (years)
30–39
40–49
50–59
60–69

23.5
27.6
25.6
23.3

–
–
–
–

33.0
29.8
20.6
16.6

Region
Metropolitan
Rural

64.6
35.4

65.0
35.0

65.6
34.4

Education
School only
Post-school

62.0
38.0

59.9
40.1

58.5
41.5

Occupation
Full-time paid
Part-time paid
Unemployed
Student
Other

29.0
28.2
1.1
1.1
40.5

31.2
29.5
1.1
1.2
37.1

28.6
24.9
3.6
2.1
40.9

Country of birth
Australia
Other

77.6
23.4

77.7
22.3

68.9
31.1

Table 1 Comparison of demographic
characteristics of the study population,
age-adjusted study population and the
general population of women aged
30–69 years in NSW

*According to Australian Bureau of Statistics census data.27
Includes home duties and retired.
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Table 2 Preferred decision-making role for tests and treatment (by age)
Age group (%)
30–39

40–49

50–59

60–69

n ¼ 204
12.3
28.4
52.0
5.0
2.0

n ¼ 193
13.0
32.8
55.4
4.7
3.1

n ¼ 147
16.3
27.2
50.3
3.4
2.7

n ¼ 105
3.8
14.3
63.8
6.7
11.4

n ¼ 202
4.5
37.1
55.0
3.5
0.0

n ¼ 194
5.7
36.8
52.8
1.6
3.1

n ¼ 147
9.5
30.6
56.5
2.0
1.4

n ¼ 104
3.8
23.1
59.6
6.7
6.7

Preferred test decision-making role
Woman decides
Woman decides after considering doctor’s opinion
Decide together
Doctor decides after considering woman’s opinion
Doctor decides
Preferred treatment decision-making role
Woman decides
Woman decides after considering doctor’s opinion
Decide together
Doctor decides after considering woman’s opinion
Doctor decides

Table 3 Reported decision-making role and information preferences for test and treatment among women with a regular doctor
Test category (%)

Blood test,
n ¼ 383

X-ray,
n ¼ 83

Other imaging
tests,
n ¼ 51

All tests (except
pap smears),
n ¼ 517

Pap smear,
n ¼ 29

Treatment (%),
n ¼ 590

Reported decision-making role*
Woman decided
Decided together
Doctor decided

11.5
40.7
47.8

10.8
34.9
54.2

7.7
50.0
42.3

11.0
40.8
48.2

48.3
34.5
17.2

5.4
75.4
19.1

Information on beneﬁts*
Wanted more
As much as wanted
More than wanted

18.5
79.4
2.1

18.0
80.7
1.2

15.6
82.4
2.0

17.6
79.8
2.6

16.6
66.7
16.7

23.4
73.5
3.0

Information on side-effects
Wanted more
As much as wanted
More than wanted

46.5
52.7
0.8

54.2
45.8
–

46.1
51.9
1.9

47.6
51.4
1.0

48.2
51.7
51.7

34.3
63.3
1.8

*Signiﬁcant difference between blood test, X-ray, scan and pap smear comparisons (P < 0.05).

doctor’s opinion (active role). In addition,
women who were in paid employment were
more likely to prefer an active role in decisions
about tests (v2 ¼ 42.000, 24 df, P ¼ 0.013).
Women residing in rural areas (v2 ¼ 14.240,
4 df, P ¼ 0.007) were more likely to prefer an
active treatment decision-making role. Country
of birth was not signiﬁcantly related to preferred
test or treatment role.

Reported test and treatment decision-making
experience
A total of 628 women were able to recall
undergoing a test and to name or describe that
test. Table 3 shows the reported test decisionmaking role by test category for those women
who could recall a test and who had a usual
doctor (n ¼ 546). For comparison, women’s

Ó Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340

336 Medical tests: women’s preferences and experience, H M Davey et al.

reported treatment decision-making role is also
shown, although details of the speciﬁc treatment
women had in mind when answering this question were not collected.
There was a signiﬁcant diﬀerence in decision-making role (v2 ¼ 38.678, 6 df, P < 0.001)
reported by women in the diﬀerent test categories. However, the diﬀerence appears to
relate to women who nominated pap smears.
With the exception of these women, the pattern for reported decision-making role and
information about beneﬁts and side-eﬀects is
fairly consistent between tests, but diﬀers from
that for treatment. Reported decision-making
role for tests was not associated with any of
the demographic variables. Women with more
education (v2 ¼ 4.569, 1 df, P < 0.033) and
those born overseas reported wanting more
information about test beneﬁts (v2 ¼ 10.674,
3 df, P ¼ 0.014). There was no relationship
between satisfaction with information on
beneﬁts and age, region or occupation. People
in ÔotherÕ occupations, including home duties
and retired reported wanting less information about side-eﬀects (v2 ¼ 30.842, 12 df,
P < 0.002). None of the other demographic
variables were associated with satisfaction with
information about side-eﬀects.
For treatment decisions, women with less
education were more likely to report the doctor
made the decision alone (v2 ¼ 10.150, 1 df, P ¼
0.001). Reported treatment decision-making role
was not signiﬁcantly related to age, region,
occupation or country of birth.
Satisfaction with information about beneﬁts
and side-eﬀects was not related to any of the
demographic variables.
Women without a usual doctor
A total of 54 women reported not having a
usual doctor. These women were more likely
than those with a usual doctor to report the
doctor made the test decision (v2 ¼ 8.863, 2 df,
P ¼ 0.012). For tests, 3.8% women said they
made the decision alone, 67.3% the doctor made
the decision and 28.8% shared decision-making
with the doctor. There was no diﬀerence by age,
region, education, occupation or country of

birth. For treatment decisions, information was
collected separately for women without a usual
doctor. These women were asked to think about
their last doctor. A total of 36.2% women said
they made the decision, 35.4% the doctor made
the decision and 28.4% shared decision-making
with the doctor. There was no association with
any demographic variable.
Reported breast test decision-making experience
A total of 60.6% of women reported having
ever undergone a mammogram. Signiﬁcantly,
more women with a usual doctor (62.4%) than
without (42.1%) reported having had a
mammogram (v2 ¼ 8.930, 1 df, P ¼ 0.003).
Women aged 50 years and over were more
likely to have had a mammogram (v2 ¼
216.932, 1 df, P < 0.001), but less likely to have
had a diagnostic mammogram (v2 ¼ 46.296,
1 df, P < 0.001). Women who reported having
had a diagnostic mammogram were asked to
focus on that, all others to focus on their most
recent screening mammogram. Women aged
50 years and older and those who had undergone diagnostic mammography were more
likely to report the doctor made the decision
(v2 ¼ 5.279, 1 df, P ¼ 0.022, v2 ¼ 85.786, 2 df,
P < 0.001, respectively). Overall, more women
reported being satisﬁed with the information
they received about beneﬁts than the information they received about side-eﬀects (Table 4).
Reported decision-making role and satisfaction
with beneﬁts and side-eﬀects was not related to
any demographic variable.
Women without a usual doctor
Women aged 50 years and older (v2 ¼ 17.451,
1 df, P < 0.001) and those living in non-metropolitan areas were more likely to have had a
mammogram (v2 ¼ 6.814, 1 df, P ¼ 0.009).
There was no diﬀerence by education, occupation or country of birth. Fewer women without a
usual doctor were satisﬁed with the information
they received. A total of 62.5% of women
without a usual doctor were satisﬁed with the
information they received on beneﬁts, while
37.5% wanted more information. 54.2% wanted
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Table 4 Reported decision-making
role and information preferences for
breast tests among women with a
regular doctor

Diagnostic
mammogram (%),
n ¼ 177

Screening
mammogram (%),
n ¼ 259

Timing of last mammogram
<2 years ago
2–5 years ago
6–10 years ago
>10 years ago

27.0
40.0
17.1
15.9

80.3
16.5
2.7
0.5

Reported decision-making role*
Woman decided
Decided together
Doctor decided

45.5
49.4
36.0

60.6
25.7
13.8

Information on beneﬁts
Wanted more
As much as wanted
More than wanted

23.8
73.8
2.3

18.1
79.2
2.7

Information on side-effects
Wanted more
As much as wanted
More than wanted

41.2
57.6
1.2

33.2
65.9
0.9

*Signiﬁcant difference between diagnostic and screening mammogram (P < 0.001).

more information about side-eﬀects, 41.7% were
satisﬁed with the information they received and
4.2% wanted less information.
Breast biopsy
A total of 11.5% of women reported having
ever had a breast biopsy. More women aged
50 years or older reported having had a breast
biopsy (v2 ¼ 184.348, 1 df, P < 0.001). There
was no diﬀerence by region, education, occupation or country of birth. More women
reported being satisﬁed with the information
they received on beneﬁts (67.2%) than on
side-eﬀects (42.5%). More information about
beneﬁts was wanted by 30.8% of women and
57.5% wanted more information about sideeﬀects. There were no diﬀerences by any
demographic variable.
Information on test accuracy
False results
Women most commonly reported their doctor
never explained the possibility of a false test
result (see Table 5). Although most women
wanted information about false results the next

time they had a medical test, women less than
60, and students and women in paid work were
more likely to want this information (v2 ¼
5.687, 1 df, P ¼ 0.017; v2 ¼ 27.000, 12 df, P ¼
0.008, respectively). Many women predicted the
information would make them anxious but
reported they wanted the information anyway.
Women with less education (v2 ¼ 15.533, 1 df,
P < 0.001) were more likely to predict information about false results would make them
anxious.
Side-eﬀects
One third of women said their doctor never
explained a test may have side-eﬀects (see Table 5).
Women less than 50 (v2 ¼ 10.851, 1 df, P ¼ 0.001)
and women born in Australia (v2 ¼ 14.796, 3 df,
P ¼ 0.002) were more likely to report their
doctor at least sometimes explained a test might
have a side-eﬀect. Almost all women wanted
information about side-eﬀects the next time
they had a test, even though many reported
it would make them anxious. Women aged
30–39 were more likely to want this information
the next time they had a test (v2 ¼ 6.733,
1 df, P ¼ 0.009). Women with less education
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Table 5 Desire for and anxiety related to information about
the possibility of a false test result and test side-effects
False
Sideresults (%) effects (%)
Possibility of this explained
Always
Often
Sometimes
Never

n ¼ 573
18.3
13.1
28.8
40.0

n ¼ 549
28.6
14.6
25.5
31.3

Want this information
Deﬁnitely yes
Probably yes
Probably no
Deﬁnitely no

n ¼ 582
65.1
25.9
5.5
3.4

n ¼ 591
77.5
17.8
2.4
2.4

Information cause anxiety
Deﬁnitely yes
Probably yes
Probably no
Deﬁnitely no

n ¼ 580
16.4
30.2
24.7
18.8

n ¼ 572
10.1
33.0
32.9
24.0

Want information despite anxiety* n ¼ 365
Yes
77.6
No
16.2
Don’t know
6.2

n ¼ 280
88.1
9.6
2.2

*Among those women who reported this information would deﬁnitely
or probably make them anxious.

(v2 ¼ 9.493, 1 df, P ¼ 0.002) were more likely to
predict this information would make them
anxious.

Discussion
This survey is the ﬁrst to interview a community
sample about their preferences for involvement
in test decisions and their information needs in
relation to tests. The sample is representative of
the general population of women aged 30–
69 years in NSW as derived from Australian
census data,27 given that we deliberately over
sampled older women, and achieved a high response rate. Thus, the results are likely to be
applicable in other similar Western populations,
although the transferability of the ﬁndings to
other populations needs to be assessed.
The most striking ﬁnding of the study is that
the majority of women reported they would
prefer to participate equally in decision-making
with their doctor for decisions about both tests
and treatment or to take a more active role. This

ﬁnding was consistent across all age groups.
Overall, only a small proportion of women
(0.0–11.4%) reported they would want the doctor to make the decision on their behalf. The
preference for shared decision-making is consistent with previous research on treatment
preferences in community16 and non-patient
samples.3,11,14,15 However, this is the ﬁrst study
to document similar preferences for shared decision-making in decisions about tests. Although
preferences were very similar, women’s reported
experiences were strikingly diﬀerent for tests and
treatment. While the majority reported shared
decision-making for treatment, overall the most
common experience of test decision-making
(excluding pap smears) was the doctor deciding
alone. Thus, a discrepancy between preferences
and reported experience is apparent in the arena
of test decisions.
There were a number of diﬀerences in the
demographic factors associated with the preferred decision-making role for tests and treatment. In particular, age was related to preferred
test and treatment decisional role and receiving
and wanting information about side-eﬀects with
younger women being more likely to want active
involvement and more information. Education
was also related to preferred test and treatment
decisional role, satisfaction with information
about test beneﬁts, reported treatment decisional
role, and predicted anxiety about information on
false results and side-eﬀects. The relationship
between age and preferred treatment decisionmaking role is consistent with previous research,
showing younger women are more likely to want
an active role in decision-making.8,28–30 In addition, the relationship between education and
preferred treatment decision-making role is also
consistent with previous research showing people
with more education prefer greater participation
in decision-making.29,31 However, it is unclear to
what extent these demographic relationships are
practically important, as previous research has
found that demographic factors account for not
more than 15% of the variation in decisionmaking preference for treatment decisions.11,28
Therefore, it cannot be assumed that individuals
who belong to demographic groupings generally
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disinterested in active decision-making will
themselves be so disinterested. Doctors may need
to establish information and involvement preferences with each patient, perhaps at each consultation in order to clarify the patient’s current
preferences, as there is evidence that preferences
may vary over time.25
In this study, women with a usual doctor were
signiﬁcantly more likely to report an active role
in test and treatment decision-making. This
ﬁnding suggests that a pre-existing doctor–
patient relationship may aﬀect the extent to
which a patient participates in decision-making.
Further research is needed to determine if, and
to what extent a pre-existing doctor–patient
relationship inﬂuences the role a patient plays in
making test and treatment decisions.
Women reported they want to be wellinformed about the possibility of receiving a
false test result, and about any adverse eﬀects of
tests. A large proportion of the women surveyed
reported not being regularly informed that a test
could have a false result or side-eﬀects, and they
reported being more satisﬁed with the information they received on the beneﬁts of treatments and tests than the information on adverse
eﬀects. If women are not receiving balanced
information about tests, it is questionable whether they are making an informed decision to
undergo the test. It should be noted that this
study relied on reported information: whether
information is being provided but not ÔheardÕ
needs to be assessed.
In addition, many women recognized that
being more informed about tests may provoke
anxiety. These women nevertheless reported a
strong desire for such information, even if they
expect it will trigger anxiety. This ﬁnding supports guidelines released by The General Medical Council in the United Kingdom about the
information that should be provided to people
about the consequences of undergoing screening
tests,17 including the probability of receiving a
false report, and any adverse eﬀects of the test or
follow-up tests. Given that this study has included both screening and diagnostic tests, it seems
reasonable that this recommendation should
extend to people undergoing diagnostic tests.

The results also suggest that health-care providers, including family doctors, need to be
aware that many women want information
about test accuracy, that such information may
cause anxiety, but that this anxiety does not
prevent many women from wanting the information. Thus, health-care providers should not
use concerns about anxiety to prevent them from
oﬀering women the chance to receive this information or providing it in cases where women want
it. Combined with the ﬁndings on preferred
decision-making role for tests, it appears that
most women want information about test accuracy but also want input by the doctor into the
decision about whether to undergo a test.
Before the ﬁndings of this study can be
eﬀectively incorporated into clinical practice and
health-care professionals start providing this
information, it would be pertinent to assess what
type of information women want about test
beneﬁts, side-eﬀects and the possibility of a false
result; who they want to provide the information;
when they want to receive it; how they want it
presented; and what, if any, between-test diﬀerences exist. For example, do women want detailed
statistical information about every possible sideeﬀect; do they want to know the more common
side eﬀects or only the serious ones? Do they want
this information in a booklet or from a doctor?
These questions need to be answered as the provision of information about side-eﬀects, beneﬁts
and false results is necessary if women are to be
fully informed and able to participate in decisions
about whether to undergo medical tests.
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